Paediatric Success Rate in India
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
Paediatric Treatment Success Rate in India
Understanding the Paediatric success rate in India is crucial for families seeking healthcare decisions. Treatment outcomes can vary significantly, depending on the specific condition, the chosen therapeutic approach, and the child's individual health profile. This page reviews general trends in paediatric care within India, offering a data-informed perspective.
Success rates in India are assessed by analyzing aggregated clinical data and evaluating treatment-level outcomes. These findings are often compared against national and international benchmarks. Outcome variations are influenced by factors such as the type of illness, its stage at diagnosis, and the patient’s overall health status.
Understanding Paediatric Treatment Outcomes
For paediatric treatments, "success" encompasses various positive outcomes. It can signify complete recovery from an illness, effective control of a chronic condition, significant improvement in functional abilities, or enhanced quality of life for the child. Success also involves achieving long-term disease-free survival, depending on the specific health challenge being addressed and the patient's individual prognosis.
Paediatric Treatment Success Rate Breakdown in India
Success rates vary depending on treatment approach and patient factors.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Paediatric Oncology (e.g., Leukemias) | Treating childhood cancers like Acute Lymphoblastic Leukemia. | 70%–90% | Long-term remission or cure, disease-free survival. |
| Paediatric Cardiology (e.g., CHD Repair) | Corrective surgery for congenital heart defects. | 85%–95% | Successful repair, improved heart function, normal development. |
| Paediatric Neurology (e.g., Epilepsy Management) | Controlling seizures and improving developmental outcomes. | 60%–80% | Significant reduction in seizure frequency, enhanced quality of life. |
| Management of Acute Infections | Treating severe bacterial or viral infections in children. | 80%–95% | Full recovery, resolution of infection, prevention of complications. |
Paediatric Survival Rate by Age in India and Stage-wise Variations
The Paediatric survival rate in India is notably influenced by a child's age at diagnosis and the disease stage, aligning with globally observed clinical patterns. Younger patients, particularly infants, may present unique challenges due to their developing physiology, while early stage diagnoses generally yield higher recovery probabilities. Leading centers such as AIIMS, Tata Memorial Centre, and major institutes follow evidence-based protocols, improving outcomes for various age groups and stages.
| Age Group / Patient Category | Condition Stage / Treatment Focus | Paediatric Recovery Rate Range (%) |
|---|---|---|
| Infants (0-1 year) | Early Stage Conditions (e.g., specific congenital anomalies) | 75%–90% |
| Young Children (1-12 years) | Early Stage Oncology / Acute Infectious Diseases | 70%–90% |
| Young Children (1-12 years) | Advanced Stage Conditions (e.g., complex chronic diseases) | 50%–70% |
| Adolescents (13-18 years) | Early Stage Conditions (e.g., treatable cancers, surgical needs) | 65%–85% |
| Adolescents (13-18 years) | Advanced Stage / Complex Chronic Conditions | 40%–60% |
Comparing Paediatric Treatment Outcomes: India vs. Global
The Paediatric survival rate in India is often comparable with international standards, particularly when similar treatment protocols, advanced technology, and rigorous patient selection criteria are applied. India’s healthcare infrastructure has made significant strides, aligning outcomes with leading global institutions across many paediatric specialities.
| Country | Paediatric Treatment Success Rate Range (%) |
|---|---|
| India | 65%–85% |
| United States | 70%–90% |
| United Kingdom | 68%–88% |
| Germany | 70%–88% |
| Singapore | 70%–90% |
| Australia | 68%–87% |
Success rates are always indicative and can vary widely based on individual patient characteristics and specific treatment approaches. These figures should not be interpreted as guaranteed outcomes.
Factors Influencing Paediatric Treatment Success Rate
- Severity and specific type of the paediatric condition.
- Patient's age and overall general health status.
- Timeliness of diagnosis and initiation of treatment.
- Access to specialized paediatric medical expertise and facilities.
- Adherence to prescribed treatment protocols and follow-up care.
- Presence of co-existing medical conditions or complications.
- Nutritional status and immune system strength of the child.
Reliable Data Sources for Paediatric Outcome Analysis
- National health registries and disease-specific databases.
- World Health Organization (WHO) and International Agency for Research on Cancer (IARC) reports.
- Peer-reviewed medical journals and clinical research studies.
- Aggregated multi-hospital outcome data from accredited institutions.
Informed Choices for Paediatric Care
Empowering families with clear, data-driven insights supports confident and informed decision-making regarding paediatric healthcare. Always discuss specific treatment options and expected outcomes with medical professionals.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.
Artemis Hospital
Sector 51, Gurugram, Haryana, India
Lokmanya Hospitals
Not Specified
White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India
Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.